July 30, 2014

UAB begins advanced drug trial for potentially fatal pregnancy complication

The University of Alabama at Birmingham has enrolled the first patient in the United States in a Phase III clinical trial to find a treatment for preeclampsia. Preeclampsia affects a relatively small number of pregnancies – 5 to 8 percent – but its prevalence is growing.

Additional Info

UAB in the News

 
 
Back to Top